[Federal Register Volume 83, Number 114 (Wednesday, June 13, 2018)]
[Notices]
[Page 27632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12685]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Johnson 
Matthey Pharmaceutical Materials Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before August 13, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
January 1, 2018, Johnson Matthey Pharmaceutical Materials Inc., 25 
Patton Road, Devens, MA 01434 applied to be registered as a bulk 
manufacturer for the basic classes of controlled substances:

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Amphetamine..............................            1100  II
Methylphenidate..........................            1724  II
Nabilone.................................            7379  II
Hydrocodone..............................            9193  II
Levorphanol..............................            9220  II
Alfentanil...............................            9737  II
Remifentanil.............................            9739  II
Sufentanil...............................            9740  II
------------------------------------------------------------------------

    The company plans to utilize this facility to manufacture small 
quantities of the listed controlled substances in bulk for distribution 
to its customers as well as to conduct analytical testing in support of 
the company's primary manufacturing facility in West Deptford, New 
Jersey.

    Dated: June 6, 2018.
John J. Martin,
 Assistant Administrator.
[FR Doc. 2018-12685 Filed 6-12-18; 8:45 am]
 BILLING CODE 4410-09-P